Sobczuk, P.; Kozak, K.; Kopeć, S.; Rogala, P.; Świtaj, T.; Koseła-Paterczyk, H.; Gos, A.; Tysarowski, A.; Rutkowski, P.
The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma. Cancers 2022, 14, 777.
https://doi.org/10.3390/cancers14030777
AMA Style
Sobczuk P, Kozak K, Kopeć S, Rogala P, Świtaj T, Koseła-Paterczyk H, Gos A, Tysarowski A, Rutkowski P.
The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma. Cancers. 2022; 14(3):777.
https://doi.org/10.3390/cancers14030777
Chicago/Turabian Style
Sobczuk, Paweł, Katarzyna Kozak, Sylwia Kopeć, Paweł Rogala, Tomasz Świtaj, Hanna Koseła-Paterczyk, Aleksandra Gos, Andrzej Tysarowski, and Piotr Rutkowski.
2022. "The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma" Cancers 14, no. 3: 777.
https://doi.org/10.3390/cancers14030777
APA Style
Sobczuk, P., Kozak, K., Kopeć, S., Rogala, P., Świtaj, T., Koseła-Paterczyk, H., Gos, A., Tysarowski, A., & Rutkowski, P.
(2022). The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma. Cancers, 14(3), 777.
https://doi.org/10.3390/cancers14030777
